We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 136

Federal Right To Try Legislation - Is It Any Better? - 2018 Edition
  • Reed Smith LLP
  • USA
  • March 23 2018

A little more than six months ago, we reviewed then-pending federal right-to-try legislation. Since then it’s become a shiny object, capable of


More Legislation To Watch
  • Reed Smith LLP
  • USA
  • January 29 2018

Like a lot of large firms, Reed Smith has a number of blogs. We don't mention them much because, DDL has product liability pretty well covered, and


The Highs Celebrating the Ten Best Prescription DrugMedical Device Decisions of 2017
  • Reed Smith LLP
  • USA
  • December 28 2017

Ending the year on a high note is one thing that the blog tries to do - with the top ten drugdevice product liability decisions of the year


Inauspicious Debut for Depakote Plaintiffs’ First Amendment Argument
  • Reed Smith LLP
  • USA
  • December 27 2017

We've been aware of the other side attempting to construct a First Amendment counter-argument to our preemption defense for some time. It first


The Lows Mourning the Worst Prescription DrugMedical Device Decisions of 2017
  • Reed Smith LLP
  • USA
  • December 21 2017

The second most successful college basketball coach of all time (in terms of NCAA Division 1 national championships) has said "All of life is peaks


Guest Post: Christmas Came Early on December 8 - Favorable Developments in Fosamax & Accutane Litigation
  • Reed Smith LLP
  • USA
  • December 14 2017

This guest post is by Kevin Hara, an associate at Reed Smith and relatively frequent contributor to the Blog. Here, he discusses two recent favorable


Guest post - Observations on FDA 3D Printing Guidance
  • Reed Smith LLP
  • USA
  • December 7 2017

This guest post is by Reed Smith‘s Matthew Jacobson. It discusses the FDA’s recent guidance on the hot topic of 3D printing as a manufacturing


Unavoidably Unsafe PMA Medical Devices
  • Reed Smith LLP
  • USA
  • November 30 2017

When it comes to design defect claims and FDA pre-market approved (“PMA”) medical devices, “preemption” is our reflexive reaction. That’s entirely


PMA Preemption & Fraud by OmissionConcealment
  • Reed Smith LLP
  • USA
  • November 29 2017

As our PMA preemption scorecard makes clear, warning claims are preempted under Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), because the


The Opioid Epidemic - What Kind of a Problem Is It?
  • Reed Smith LLP
  • USA
  • November 27 2017

We know that our blogposts are carried by legal aggregating services, such as Lexology and JDSupra. Some of you may even be reading this post via one